Liquidation services resell returned items, a $644 billion business

Inside Liquidity Services’ 130,000-square-foot warehouse in Garland, Texas, the aisles aren’t lined with typical merchandise. Instead, they’re stacked with returns from Amazon, Targe...

Why the U.S. is facing a paint shortage

Demand for raw materials in the paint industry soared over the pandemic as quarantined consumers took to DIY projects and home improvement. But supply just couldn’t keep up. “The raw-mater...

at-home testing, from Covid to cancer, worth $2 billion dollars

The at-home testing market is bigger than just Covid tests, and it’s bigger than over-the-counter pregnancy tests. In fact, the emerging marketplace of consumer-initiated lab testing may be wort...

How Suburban Sprawl’s Single-Family Home Zoning Limits Housing Supply

America’s suburbs are sprawling again. Last year, single family housing starts rose to 1.123 million, the highest since 2006, according to the National Association of Home Builders, however, opt...

Obamacare plans are more affordable, helping the Great Resignation

Workers are quitting their jobs in record numbers – part of what is now called The Great Resignation. Around 4 million workers have quit each month between July and November 2021. Erica Leman had main...

What really happens to them?

Sending back an online order has never been easier. It’s often free for the customer, with some retailers even allowing customers to keep the item while offering a full refund. Amazon returns ca...

Why Moderna, Pfizer and the NIH debate who owns the Covid vaccine

It’s been well over a year since a landmark proposal brought the issue of patent waiver for the mRNA Covid vaccine to the spotlight. But many observers don’t see that waiving the intellect...

How U.S. economic sanctions work

Economic sanctions remain one of the most powerful tools the United States has in its foreign policy arsenal. And as Russian forces continue to amass along the border with Ukraine, officials in the U....

Johnson & Johnson splitting itself up could come with some risks

Johnson & Johnson announced in November that it plans to spin off its consumer business into a new publicly traded company by November 2023. The news didn’t surprise Wall Street. “The ...

Why Biogen’s Alzheimer’s drug Aduhelm is so controversial

The U.S. Food and Drug Administration’s approval of Biogen’s Alzheimer’s drug Aduhelm in June was heralded as a historic triumph in the fight against a disease that kills thousands o...